Cerebrolysin inhibits lipid peroxidation induced by insulin hypoglycemia in the brain and heart of mice

Physiological Research

Volumn 52, Issue 4, 2003, Pages 455-460

  Patockova J ^a   Krsiak M ^a   Marhol, P ^a   Tumova E ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cerebrolysin; Hypoglycemia; Lipid peroxidation; TBARs

Indexed keywords

BARBITURIC ACID DERIVATIVE; CEREBROLYSIN; GLUCOSE; INSULIN; LACTIC ACID; MALONALDEHYDE; MEMBRANE LIPID; PROTEIN; TRIACYLGLYCEROL;

ACIDOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CELL STRUCTURE; CONTROLLED STUDY; DECAPITATION; HEART; HYPOXIA; INSULIN HYPOGLYCEMIA; ISCHEMIA; LIPID PEROXIDATION; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN;

AMINO ACIDS; ANIMALS; BLOOD GLUCOSE; BLOOD PROTEINS; BRAIN CHEMISTRY; HEART; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; LACTIC ACID; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED ICR; MYOCARDIUM; NEUROPROTECTIVE AGENTS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES;

EID: 0041926741     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. AGARDH CD, ZHANG H, SMITH ML, SIESJÖ BK: Free radical production and ichemic brain damage - influence of postischemic oxygen tension. Int J Dev Neurosci 9: 127-138, 1991.
2. AKAI F, HIRUMA S, SATO T, IVAMOTO N.: Neurotrophic factor-like effect of FPF 1070 on septal cholinergic neurons after transsections of fimbria-fornix in the rat brain. Histol Histopathol 7: 213-221, 1992.
3. ALTOMARE E, VENDEMIALE G, CHICCO D, PROSACCI V, CIRELLI F: Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabet Metabol 18: 264-271, 1992.
4. BAROLIN GS, KOPPI S, KAPELLER E: Old and new aspects of stroke treatment with emphasis on metabolically active medication and rehabilitative outcome. Eurorehab separatum 3: 135-143, 1996.
5. BIESENBACH G, EICHBAUER-STURM G, GRAFINGER P, ZAZGORNIK J: Effect of Cerebrolysin in the treatment of painful diabetic neuropathy in type 2-diabetic patients. Eurorehab separatum 3-4: 97-103, 1997.
6. BOADO R: Brain-derived peptides regulate the steady state levels and increase stability of the blood-brain barrier GLUT1 glucose transporter mRNA. Neurosci Lett 197: 179-182, 1995.
7. BOADO R: Brain-derived peptides increase the expression of a blood-brain barrier GLUT1 glucose transporter reporter gene. Neurosci Lett 220: 53-56, 1996.
8. BOADO R: Brain-derived peptides increase blood-brain barrier GLUT1 glucose transporter gene expression via mRNA stabilisation. Neurosci Lett 255: 147-150, 1998.
9. BRALET J, BOUVIER CH, SCHREIBER L, BOQUILLON M: Effect of acidosis on lipid peroxidation in brain slices. Brain Res 539: 175-177, 1991.
10. FRIDOWICH I: The biology of oxygen free radicals. Science 201: 875-880, 1978.
11. GAY RJ, MCCOMB RB, BROWERS GN: Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity. Clin Chem 14: 740-53, 1968
12. GSCHANES A, BOADO R, SAMETZ W, WINDISCH M: The drug Cerebrolysin and its peptide fraction E021 increase the abundance of the blood-brain barrier GLUT1 glucose transporter in brains of young and old rats. Histochem J 32: 71-77, 2000
13. HUTTER-PAIER B, FRÜHWIRTH M, GRYGAR E, WINDISCH M: Cerebrolysin protects neurons from ischemi-induced loss of microtubule-associated protein 2. J. Neural Transm Suppl. 47: 276, 1996.
14. HUTTER-PAIER B, GRYGAR E, FRÜHWIRTH M, TEMMEL I, WINDISCH M: Further evidence that Cerebrolysin protects cortical neurons from neurodegeneration in vitro. J Neural Transm Suppl. 53: 363-372, 1998.
15. LAVICKÝ J, RAŠKOVÁ H, MÜHLBACHOVÁ E, STAREC M, ŠVIHOVEC J: Different stressors and blood lipid peroxidation. In: Stress: Neuroendocrine and Molecular Approaches, R KVĚTŇANSKÝ, R MCCARTHY, J AXELROD (eds), Gordon and Breach Science Publishers, New York, 1992, pp 655-662.
16. MASLIAH E, ARMASOLA F, VEINBERGS I, MALLORY M, SAMUEL W: Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice. Pharmacol Biochem Behav 62: 239-245, 1999.
17. OHKAWA H, OHISHI N, YAGI K: Assay of peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979.
18. PATOČKOVÁ J, KRŠIAK M, WINDISCH M: The influence of insulin-induced hypoglycemia on the heart muscle in mice and the possible cardioprotection. Fundam Clin Pharmacol 10: 67, 1996.
19. PATOČKOVÁ, J, MARHOL P, TŮMOVÁ E, KRŠIAK M, ROKYTA R, ŠTÍPEK S, CRKOVSKÁ J, ANDĚL M: Oxidative stress in the brain tissue of laboratory mice with acute post-insulin hypoglycemia. Physiol Res 52: 131-135, 2003.
20. RÜTHER E, RITTER R, APECECHEA M, FREYTAG S, WINDISCH M: Efficacy of the peptidergic nootropic drug Cerebrolysin in patients with senile dementia of Alzheimer's type (SDAT). Pharmacopsychiatry 27: 32-40, 1994.
21. RYBKA J, BĚLÍK P, GREGOROVÁ, A, JAROŇ P, KALITA Z, MASÁR L, MISTRÍK J, NOVOSAD P, ROUBALÍK J, SMEČKA Z, ŠINDLÁŘ M, URBÁNEK R, ZAVŘEL M, ZMYDLENÁ A: Oxidative stress and generation of diabetic complications(in Czech). In: Advances in Diabetology 1, Avicenum, Prague, 1990, pp 88-104.
22. SELVAM R, ANURADHA CV: Lipid peroxidation and peroxidative enzyme changes in erythrocytes in diabetes mellitus. Indian J Biochem Biophys 25: 268-272, 1988.
23. SCHWAB M, BAUER R, ZWIENER U: Physiological effects and brain protection by hypothermia and Cerebrolysin after moderate forebrain ischemia in rats. Exp Toxicol Pathol 49: 105-116, 1997.
24. SUGITA Y, KONDO T, KANAZAWA A, ITOU T, MIZUNO Y: Protective effects FPF1070 (Cerebrolysin) on delayed neuronal death in the gerbil-detection of hydroxyl radicals with salicylic acid. No To Shinkei 45: 325-331, 1993.
25. VERESHCHAGIN NV, NEKRASOVA EM, LEBEDOVA NV, SUSLINA ZA, SOLOVIEV OI, PIRADOV MA, ALTUNINA M: Mild forms of multi-infarct dementia: efficacy of Cerebrolysin (in Russian). Sov Med 11: 6-8, 1991.
26. WINDISCH M, GSCHANES A, HUTTER-PAIER B: Neurotrophic activities and therapeutic experience with a brain derived peptide preparation. J Neural Transm Suppl. 53: 289-298, 1998.
27. WOLF SP: The potential role of oxidative stress in the diabetic complications - novel implications for theory and therapy. In: Diabetic Complications and Clinical Aspects, Churchill Livingstone, Edinburgh, 1987, pp 167-220.